Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...
As the use of generative AI continues to expand, 2025 is poised to be the year this technology significantly starts to change how Americans live and work. This is especially true in the P&C industry, ...
"We are excited to welcome Karen to the Board of Directors. Karen’s financial expertise and deep understanding of the biotech landscape will play a crucial role in guiding our strategic initiatives ...